AlphaGrep UK’s NOV NOV Stock Holding History

AlphaGrep UK’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,206	Closed	-$238K	–	888
2025 Q4	$238K	Buy	+15,206	New	+$226K	0.08%	556

Other funds holding NOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AlphaGrep UK's NOV Position: Q1 2026 in Review

AlphaGrep UK sold out of NOV (NOV) in Q1 2026, closing a stake of 15,206 shares — an estimated $238K sold.

AlphaGrep UK first reported a position in NOV in Q4 2025 and held it in 1 quarter. The position peaked at $238K in Q4 2025. 465 funds tracked by Wall St. Rank hold NOV as of Q1 2026.

AlphaGrep UK reported no remaining NOV position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK sold 15,206 NOV shares in Q1 2026, an estimated $238K.
AlphaGrep UK first reported a position in NOV in Q4 2025 and held it in 1 quarter.
AlphaGrep UK's NOV position peaked at $238K in Q4 2025.
465 funds tracked by Wall St. Rank held NOV as of Q1 2026.

Based on AlphaGrep UK's 13F filing for Q1 2026, filed 13 Aug 2026.